GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹117 Cr | ₹125 Cr | ₹111 Cr | ₹32 Cr | ₹43 Cr |
What is the latest Short Term Provisions ratio of GLAND PHARMA ?
| Year | Short Term Provisions |
|---|---|
| Mar2026 | ₹117 Cr |
| Mar2025 | ₹125 Cr |
| Mar2024 | ₹111 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹43 Cr |
How is Short Term Provisions of GLAND PHARMA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹117 Cr | -6.08 | |
| Mar2025 | ₹125 Cr | 12.68 | |
| Mar2024 | ₹111 Cr | 242.21 | |
| Mar2023 | ₹32 Cr | -24.44 | |
| Mar2022 | ₹43 Cr | - | |
Compare Short Term Provisions of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹48,025.7 Cr | -6.5% | -2.7% | 51.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -6.5% |
-2.7% |
51.3% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses